CUSIP: 67577R102
Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
71,813,353
-
Total 13F shares
-
2,169,473
-
Share change
-
+412,370
-
Total reported value
-
$8,073,000
-
Put/Call ratio
-
38%
-
Price per share
-
$3.73
-
Number of holders
-
32
-
Value change
-
+$1,421,030
-
Number of buys
-
17
-
Number of sells
-
9
Quarterly Holders Quick Answers
What is CUSIP 67577R102?
CUSIP 67577R102 identifies IRD - Opus Genetics, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2022
-
Previous quarter:
Q3 2021
Recent filing periods for CUSIP 67577R102:
Institutional Holders of Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) as of Q4 2021
As of 31 Dec 2021,
Opus Genetics, Inc. - Common Stock, $0.0001 par value per share (IRD) was held by
32 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,169,473 shares.
The largest 10 holders included
VANGUARD GROUP INC, TWO SIGMA ADVISERS, LP, RICE HALL JAMES & ASSOCIATES, LLC, TWO SIGMA INVESTMENTS, LP, Ikarian Capital, LLC, GEODE CAPITAL MANAGEMENT, LLC, Diametric Capital, LP, STATE STREET CORP, Richmond Brothers, Inc., and SUSQUEHANNA INTERNATIONAL GROUP, LLP.
This page lists
32
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.